Medicated Liquid Soap Global Market Report 2025

The medicated liquid soap market size has grown rapidly in recent years. It will grow from$1.43 billion in 2024 to $1.6 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period can be attributed to the increasing demand for hygiene awareness, rising health consciousness, the rise in skin-related diseases, greater adoption of personal care products, and the growing availability of medicated soap varieties.

The medicated liquid soap market size is expected to see rapid growth in the next few years. It will grow to$2.47 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth during the forecast period can be attributed to the increasing consumer preference for skin health, rising awareness about antibacterial products, the growing influence of online retail, higher disposable income in emerging markets, and a greater focus on natural and organic ingredients. Key trends in the forecast period include advancements in product formulations, innovation in packaging designs, the development of eco-friendly and sustainable products, advanced research on dermatological benefits, and innovation in personalized skincare solutions.

The increasing prevalence of skin-related issues is expected to drive the growth of the medicated liquid soap market. Skin conditions such as acne, eczema, psoriasis, rashes, and infections are becoming more common due to rising exposure to environmental pollutants, which weaken the skin's barrier and trigger irritation. Medicated liquid soap helps address these concerns by eliminating harmful microbes that cause infections, acne, and irritation. It also contains active ingredients that cleanse thoroughly while calming inflammation and promoting skin repair. For example, in February 2025, Cancer Australia reported 18,257 new cases of skin melanoma in 2023, making up 11% of all new cancer cases, with 1,314 deaths from the disease. As skin issues become more widespread, the demand for products such as medicated liquid soap is increasing, fueling market growth.

Companies in the medicated liquid soap market are innovating with advanced products, such as antibacterial liquid soap, to enhance germ protection and offer a more effective and gentle cleansing experience. Antibacterial liquid soap is formulated to eliminate or inhibit bacterial growth on the skin, reducing the risk of infection and improving hygiene. For example, in April 2023, Dettol, a leading UK-based hygiene brand, introduced a reformulated version of its original liquid hand wash. The new formula provides 99.99% germ protection and a moisture seal benefit, while being dermatologically tested for gentle care. This enhanced version leaves hands feeling soft and nourished, offering both cleanliness and skin protection. Such innovations are helping to meet the growing demand for more effective, skin-friendly hygiene products.

In December 2023, Wipro Consumer Care and Lighting, an India-based personal care company, acquired three soap brands from VVF Limited. This acquisition strengthens Wipro’s position in the hygiene and wellness category by expanding its personal wash portfolio, which includes medicated liquid soaps. VVF Limited, a manufacturer of medicated liquid soap, has been a key player in this market. By acquiring these brands, Wipro aims to increase its market share in the fast-growing personal care segment, responding to the rising consumer demand for effective hygiene products.

Major players in the medicated liquid soap market are Johnson & Johnson Services Inc., Unilever PLC, Reckitt Benckiser Group plc, Ecolab Inc., Kao Corporation, ITC Limited, Lion Corporation, Godrej Consumer Products Limited, GOJO Industries Inc., Vi-Jon LLC, Betco Corporation, Dr. Bronner’s Magic Soaps, Vanguard Soap, Kutol Products Company Inc., Cleenol, Carroll Company (CarrollClean), B4 Brands LLC, Wipro Consumer Care and Lighting, Swisskem Healthcare, Trio Lifescience Pvt. Ltd., and Kavit Soap Industries.

North America was the largest region in the medicated liquid soap market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medicated liquid soap report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medicated liquid soap market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medicated liquid soap is a specialized type of liquid soap that contains active pharmaceutical ingredients designed to treat or prevent specific skin conditions. Unlike regular cleansing soaps, medicated liquid soaps provide therapeutic benefits, often possessing antibacterial, antifungal, or anti-inflammatory properties. They are commonly used in clinical settings, dermatological treatments, and personal hygiene routines to address various skin concerns.

The main product types of medicated liquid soap include antibacterial, antifungal, antiviral, and other variants. Antibacterial medicated liquid soaps contain agents that target bacteria, helping to prevent infections and maintain personal hygiene. These soaps are made from a mix of natural and synthetic ingredients and are distributed through multiple channels, such as online stores, supermarkets, hypermarkets, specialty stores, pharmacies, and others. They are used in various applications, including household, healthcare, commercial, and industrial settings.

The medicated liquid soap market research report is one of a series of new reports that provides medicated liquid soap market statistics, including the medicated liquid soap industry global market size, regional shares, competitors with the medicated liquid soap market share, detailed medicated liquid soap market segments, market trends, and opportunities, and any further data you may need to thrive in the medicated liquid soap industry. This medicated liquid soap market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medicated liquid soap market consists of sales of botanical-based medicated soap, moisturizing medicated soap, acne-control medicated soap, and deodorizing medicated soap. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.